KAMRUKA
Live / Applied — Fifth extension granted (statement of use) (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 03 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97293347
- Mark type
- Stylized text
- Filed
- 03 Mar 2022
- Published for opposition
- 24 Jan 2023
- Attorney of record
- Connie Dai
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Hengrui USA, Ltd., Princeton, NJ, US
- Hengrui USA, Ltd., Princeton, NJ, US
Prosecution history
- 14 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2025 — SOU EXTENSION 5 GRANTED
- 20 Sept 2025 — SOU EXTENSION 5 FILED
- 14 Oct 2025 — SOU EXTENSION 4 GRANTED
- 20 Mar 2025 — SOU EXTENSION 4 FILED
- 10 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 10 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
- 10 Oct 2025 — PETITION TO REVIVE-GRANTED
- 10 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED
- 10 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2024 — SOU EXTENSION 3 GRANTED
- 03 Sept 2024 — SOU EXTENSION 3 FILED